Advanced search
Publication Cover
Infectious Diseases Volume 50, 2018 - Issue 3
Submit an article Journal homepage
317
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli

Jin Woong SuhDepartment of Internal Medicine, Division of Infectious Diseases, Korea University College of Medicine, Seoul, Republic of Korea; View further author information
,
Kyung Sook YangDepartment of Biostatistics, Korea University College of Medicine, Seoul, Republic of KoreaView further author information
,
Sun Bean KimDepartment of Internal Medicine, Division of Infectious Diseases, Korea University College of Medicine, Seoul, Republic of Korea; View further author information
,
Jong Hun KimDepartment of Internal Medicine, Division of Infectious Diseases, Korea University College of Medicine, Seoul, Republic of Korea; View further author information
,
Jang Wook SohnDepartment of Internal Medicine, Division of Infectious Diseases, Korea University College of Medicine, Seoul, Republic of Korea; View further author information
,
Min Ja KimDepartment of Internal Medicine, Division of Infectious Diseases, Korea University College of Medicine, Seoul, Republic of Korea; View further author information
&
Young Kyung YoonDepartment of Internal Medicine, Division of Infectious Diseases, Korea University College of Medicine, Seoul, Republic of Korea; Correspondence[email protected]
View further author information
 show all
Pages 241-244 | Received 08 Aug 2017, Accepted 15 Oct 2017, Published online: 31 Oct 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

All authors declare no conflict of interest.

Additional information

Funding

This research was supported financially in part by a research grant from the Investigator Initiated Studies Program of Boryung Pharm. Co., Ltd, by the National Research Foundation of Korea Grant funded by the Korean Government [no. NRF-2015R1C1A1A02036329] and by a grant of the Korea Health Technology R&B Project through the Korea Health I dustry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea [no. HI16C1048]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 174.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.